GT200900112A - Tratamiento de los trastornos generalizados del desarrollo - Google Patents
Tratamiento de los trastornos generalizados del desarrolloInfo
- Publication number
- GT200900112A GT200900112A GT200900112A GT200900112A GT200900112A GT 200900112 A GT200900112 A GT 200900112A GT 200900112 A GT200900112 A GT 200900112A GT 200900112 A GT200900112 A GT 200900112A GT 200900112 A GT200900112 A GT 200900112A
- Authority
- GT
- Guatemala
- Prior art keywords
- treatment
- development
- generalized
- disorders
- generalized disorders
- Prior art date
Links
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000029560 autism spectrum disease Diseases 0.000 abstract 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 abstract 1
- 230000006866 deterioration Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
LA PRESENTE INVENCION ESTA DIRIGIDA AL USO DE ALGUNOS COMPUESTOS DE CARBAMATO PARA EL TRATAMIENTO DE PACIENTES CON TRASTORNOS GENERALIZADOS DEL DESARROLLO (PDD'S) QUE SON UNA CATEGORIA DE TRASTORNOS NEUROLOGICOS CARACTERIZADOS POR DETERIORO SEVERO Y GENERALIZADO TALES COMO EL AUTISMO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86359506P | 2006-10-31 | 2006-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT200900112A true GT200900112A (es) | 2010-05-18 |
Family
ID=39145417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT200900112A GT200900112A (es) | 2006-10-31 | 2009-04-30 | Tratamiento de los trastornos generalizados del desarrollo |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080103199A1 (es) |
| EP (1) | EP2089011A1 (es) |
| JP (1) | JP2010508354A (es) |
| KR (1) | KR20090080105A (es) |
| CN (1) | CN101568333A (es) |
| AU (1) | AU2007313911A1 (es) |
| BR (1) | BRPI0718323A2 (es) |
| CA (1) | CA2667909A1 (es) |
| CO (1) | CO6180427A2 (es) |
| EA (1) | EA200970435A1 (es) |
| GT (1) | GT200900112A (es) |
| IL (1) | IL198488A0 (es) |
| MX (1) | MX2009004798A (es) |
| NI (1) | NI200900074A (es) |
| NO (1) | NO20092019L (es) |
| WO (1) | WO2008054984A1 (es) |
| ZA (1) | ZA200903772B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
| US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
| WO2010020585A1 (en) * | 2008-08-18 | 2010-02-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Serotonin reuptake inhibitors for the treatment of rett syndrome |
| DK2601609T3 (en) | 2010-08-02 | 2017-06-06 | Population Bio Inc | COMPOSITIONS AND METHODS FOR DISCOVERING MUTATIONS CAUSING GENETIC DISORDERS |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CA2851388C (en) | 2011-10-10 | 2023-11-21 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
| DK2773779T3 (da) | 2011-11-04 | 2020-11-23 | Population Bio Inc | Fremgangsmåder og sammensætninger til diagnosticering, prognose og forebyggelse af neurologiske tilstande |
| EP2812452B1 (en) | 2012-02-09 | 2020-05-27 | Population Bio, Inc. | Methods and compositions for screening and treating developmental disorders |
| BR112015002687A2 (pt) * | 2012-08-06 | 2019-12-17 | S1 Biopharma Inc | regimes de tratamento |
| US9976180B2 (en) | 2012-09-14 | 2018-05-22 | Population Bio, Inc. | Methods for detecting a genetic variation in subjects with parkinsonism |
| WO2014052855A1 (en) | 2012-09-27 | 2014-04-03 | Population Diagnostics, Inc. | Methods and compositions for screening and treating developmental disorders |
| US9566261B2 (en) * | 2013-03-12 | 2017-02-14 | Bio-Pharm Solutions Co., Ltd. | Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same |
| WO2016036403A1 (en) | 2014-09-05 | 2016-03-10 | Population Diagnostics Inc. | Methods and compositions for inhibiting and treating neurological conditions |
| EP3556366B1 (en) | 2016-12-14 | 2025-10-22 | SK Biopharmaceuticals Co., Ltd. | Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder |
| US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| WO2020033700A1 (en) | 2018-08-08 | 2020-02-13 | Pml Screening, Llc | Mathods for assessing the risk of developing progressive multifocal leukoencephalopathy caused by john cunningham virus by genetic testing |
| CN113993523A (zh) | 2019-04-17 | 2022-01-28 | 指南针探路者有限公司 | 用赛洛西宾治疗抑郁症和其他各种病症 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ551954A (en) * | 2001-02-27 | 2008-07-31 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating movement disorders |
| RS51055B (sr) * | 2001-02-27 | 2010-10-31 | Ortho-Mcneil Pharmaceutical Inc. | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neurodegenerativnih poremećaja |
| ATE324108T1 (de) * | 2001-02-27 | 2006-05-15 | Ortho Mcneil Pharm Inc | Carbamatverbindungen zur verwendung bei der prävention oder behandlung der bipolaren erkrankung |
| NZ527991A (en) * | 2001-02-27 | 2005-04-29 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating psychotic disorders |
| RS51269B (sr) * | 2004-09-16 | 2010-12-31 | Janssen Pharmaceutica N.V. | Upotreba 2-fenil-1,2-etandiol-(di)karbamata za tretiranje epileptogeneze |
-
2007
- 2007-10-15 US US11/872,177 patent/US20080103199A1/en not_active Abandoned
- 2007-10-15 MX MX2009004798A patent/MX2009004798A/es not_active Application Discontinuation
- 2007-10-15 AU AU2007313911A patent/AU2007313911A1/en not_active Abandoned
- 2007-10-15 BR BRPI0718323-2A patent/BRPI0718323A2/pt not_active Application Discontinuation
- 2007-10-15 KR KR1020097011061A patent/KR20090080105A/ko not_active Withdrawn
- 2007-10-15 JP JP2009535384A patent/JP2010508354A/ja not_active Withdrawn
- 2007-10-15 CN CNA2007800482055A patent/CN101568333A/zh active Pending
- 2007-10-15 EA EA200970435A patent/EA200970435A1/ru unknown
- 2007-10-15 WO PCT/US2007/081365 patent/WO2008054984A1/en not_active Ceased
- 2007-10-15 CA CA002667909A patent/CA2667909A1/en not_active Abandoned
- 2007-10-15 EP EP07844287A patent/EP2089011A1/en not_active Withdrawn
-
2009
- 2009-04-30 GT GT200900112A patent/GT200900112A/es unknown
- 2009-04-30 IL IL198488A patent/IL198488A0/en unknown
- 2009-04-30 NI NI200900074A patent/NI200900074A/es unknown
- 2009-05-25 NO NO20092019A patent/NO20092019L/no not_active Application Discontinuation
- 2009-05-29 ZA ZA200903772A patent/ZA200903772B/xx unknown
- 2009-06-01 CO CO09056106A patent/CO6180427A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2007313911A1 (en) | 2008-05-08 |
| EA200970435A1 (ru) | 2009-10-30 |
| CA2667909A1 (en) | 2008-05-08 |
| KR20090080105A (ko) | 2009-07-23 |
| NI200900074A (es) | 2010-02-01 |
| US20080103199A1 (en) | 2008-05-01 |
| WO2008054984A1 (en) | 2008-05-08 |
| NO20092019L (no) | 2009-06-23 |
| EP2089011A1 (en) | 2009-08-19 |
| IL198488A0 (en) | 2010-02-17 |
| CO6180427A2 (es) | 2010-07-19 |
| BRPI0718323A2 (pt) | 2013-11-26 |
| JP2010508354A (ja) | 2010-03-18 |
| ZA200903772B (en) | 2010-08-25 |
| MX2009004798A (es) | 2009-08-12 |
| CN101568333A (zh) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GT200900112A (es) | Tratamiento de los trastornos generalizados del desarrollo | |
| ECSP077275A (es) | Novedosos derivados de heteroarilsulfamida benzofusionados utiles como agentes anticonvulsivos | |
| DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| ECSP12011968A (es) | Nuevos compuestos tricíclicos | |
| ECSP034811A (es) | Derivados heterocicliloxi-, -tioxi - y - aminobenzazole tales como ligandos 5-hidroxitriptamina-6 | |
| SV2011003802A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
| PA8621901A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| DOP2012000151A (es) | Nuevos compuestos triciclicos | |
| ECSP088821A (es) | Derivados de tioxantina y su uso como inhibidores de la mpo | |
| ECSP066730A (es) | Compuestos y procedimientos para uso | |
| UY30572A1 (es) | N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2 | |
| ECSP14013221A (es) | Fenil-3-aza-biciclo [3.1.0] hex-3-il-metanonas y su uso como medicamento. | |
| CO6321241A2 (es) | Derivados de 1,3,4- tiadiazol espiro condensados para la inhibicion de la actividad de quinesina (ksp) | |
| GT200700103A (es) | Compuestos biciclocarboxiamida sustituidos | |
| ECSP12007795A (es) | 1h-quinazolin-2,4-dionas y su uso como ligandos del receptor de ampa | |
| CO6382118A2 (es) | Nuevas octahidrociclopenta(c)ciprol-4aminas sustituidas como bloqueantes de los canales de calcio | |
| CO6382089A2 (es) | Compuestos,composiciones y metodos para el tratamiento de enfermadades causadas por un b-amiloide y sinucleinopatias | |
| CL2012001031A1 (es) | Compuestos derivados de 2-oxo-1-pirrolidinil-imidazotiadiazol; composición farmacéutica que los comprende; útiles para el tratamiento de la epilepsia, transtornos neurológicos, entre otros. | |
| BRPI0518169A (pt) | tiazolil-dihidro-indazóis | |
| CL2008001820A1 (es) | Compuestos derivados de aril-isoxasol-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y uso en la preparacion de medicamentos utiles en el tratamiento de trastornos cognitivos y enfermedades relacionadas con alzheimer. | |
| PA8603001A1 (es) | Compuestos utiles para el tratamiento de enfermedades | |
| UY28484A1 (es) | Compuestos para el tratamiento de trastornos neurodegenerativos | |
| AR057239A1 (es) | Inmunoglobulinas | |
| NI200900073A (es) | Compuestos de carbamato para su uso en el tratamiento de la depresión. | |
| PA8627001A1 (es) | Compuestos para el tratamiento de enfermedades |